Jetstream Capital’s Novavax NVAX Stock Holding History

Jetstream Capital’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,000	Closed	-$924K	–	42
2014 Q2	$924K	Buy	+10,000	New	+$879K	0.03%	37

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Jetstream Capital's NVAX Position: Q3 2014 in Review

Jetstream Capital sold out of Novavax (NVAX) in Q3 2014, closing a stake of 10,000 shares — an estimated $924K sold.

Jetstream Capital first reported a position in NVAX in Q2 2014 and held it in 1 quarter. The position peaked at $924K in Q2 2014. 143 funds tracked by Wall St. Rank hold NVAX as of Q3 2014.

Jetstream Capital reported no remaining Novavax position as of Q3 2014 after selling out during the quarter.
Jetstream Capital sold 10,000 Novavax shares in Q3 2014, an estimated $924K.
Jetstream Capital first reported a position in Novavax in Q2 2014 and held it in 1 quarter.
Jetstream Capital's Novavax position peaked at $924K in Q2 2014.
143 funds tracked by Wall St. Rank held Novavax as of Q3 2014.

Based on Jetstream Capital's 13F filing for Q3 2014, filed 14 Nov 2014.